Sterling Bay and Harrison Street recently celebrated the structural completion of ALLY at 1229 W. Concord Pl, a new life sciences facility that will provide the city’s rapidly growing biotech community with much needed lab space along the North Branch of the Chicago River. The topping out event was attended by Sterling Bay and Harrison Street’s project leadership teams, as well as partners at Power Construction and Gensler, who marked the milestone with a traditional beam-signing ceremony.
1229 W. Concord Pl. is a 320,000-square-foot Class A development that will house industry-leading companies seeking to conduct groundbreaking life sciences research in Chicago. Designed by Gensler, the building features ultramodern amenities and expansive outdoor gathering spaces. Conveniently situated within walking distance of The Steelyard, Lincoln Yards’ future lifestyle district, tenants of 1229 W. Concord Pl will have unparalleled access to The Steelyard’s dynamic restaurants, experiential retail and over 6.5-acres of sprawling park space for sports, fitness, and riverfront recreation.
“After years of extensive planning, watching 1229 W Concord Place rise along the Chicago River at Lincoln Yards has been incredibly rewarding,” said Sterling Bay CEO, Andy Gloor. “Once complete, this state-of-the-art facility will provide tenants at the forefront of life sciences innovation with not only the latest in technological infrastructure, but also with inspiring views of Chicago’s skyline and incredible amenities that foster a healthy, collaborative workplace environment.”
Inspired by the vitality of the life sciences industry, 1229 W. Concord is light, bright, and wellness driven. With balconies on every floor, natural materials incorporated throughout, and a seamless integration with the Chicago River, the project brings in the best of the outdoors and prioritizes tenant health through its pursual of LEED Silver Certification, WELL Health-Safety Certification, and RESET Air Standard.
1229 W. Concord Pl is expected to deliver to tenants in Q4 2022.